Partnership Bears Some Early Fruit for Rare Disease
MEwens
Researchers at Weill Cornell Medical College and the University of Notre Dame said they used drugs being tested for cancer to correct a cholesterol-storage defect in a lethal, rare disease called Niemann-Pick Type C (NPC).
The researchers found that a compound called LBH589, part of a group of drugs called histone deacetylase […]